Current vaccines (Pfizer/Moderna/AZ) focus solely on the Spike protein with the primary aim to generate circulating neutralising antibodies, which are fairly short lived. T-cell response was strongest against a set of proteins, which are well conserved across coronaviruses.
4/ pic.twitter.com/2ggaMrADTM

— Prof Francois Balloux (@BallouxFrancois) November 10, 2021